exhibited 100 % inhibition rates at 10.0 mg/L. It demostrated the introduction of CF3 group is really benefit for increasing nematocidal
activity. Compared with the structure reported by Liu et al. [23,24], when pyrazole carboxamide kept the same, the highest inhibition
rates of compound 1-5 (Fig. S2) and 1-4 (Fig. S2) was 59.4% at 10.0 mg/L and 100% at 40.0 mg/L, our compounds A11 reached 100%
inhibition rates at 10.0 mg/L under the same test condition. It indicated that chromone and ester flexible chain might increase the
nemoticidal activities of our compounds.
As shown in Table 2, to determine the strength of activity of title compounds, the nematicidal evaluation of the compounds in 100%
inhibitory activity at 10.0 mg/L, such as A10 and A11, was continued at lower concentrations of 5.0 mg/L and 1.0 mg/L. However, it
was found that the inhibitory activities decreased very quickly with the decreasing of the treatment concentration. The nemoticidal
bioactivity of compound A10 was 21.4% at the treatment concentration 5.0 mg/L; that of positive control tioxazafen exhibited 92.9%.
The reason why the inhibitory rates decreased so quickly still needs to be investigated further. When the treatment concentration
decreased to 1.0 mg/L, compound A11 had 14.3% inhibitation rate, meanwhile, tioxazafen exhibited 28.6 % inhibition rates at 1.0
mg/L. Although the data is not very good, it still means that compound A11 is valuable to modify further based on that of tioxazafen.
Some literatures has reported that AChE is one of the target of nematicides [31,32]. Our high active compound was also tried to
investigate the mode with AChE, the binding modes between AChE (PDB:1odc) and the active compound A6 were selected as
exemplified in the case of representative compound. First of all, we did the docking poses of A6 with the AChE, and then did the
compound A10 and A11. Performed on Maestro 10.2 software, the most likely binding conformation was selected based on the glide
score and the binding mode, which was shown in Fig. S4 (Supporting information). From the docking result, one hydrogen bond and
four π-π stacking interactions were observed between the target and the compound A6. The H atom of amide group in alkyl chain of the
compound A6 can form tightly interaction with the OH group of Tyr121 in the hinge domain of the target via a H-bond. Meanwhile, the
benzene ring of the compound A6 formed the π-π stacking interaction with the Trp279 and Tyr70 residue. The pyridine ring of the
compound A6 formed the π-π stacking interaction with the Phe330 and Trp84 residue. All of these interactions contributed the stability
of the complex between AChE and the compound A6. It is different from the mode reported by Liu et al. [25,26]. Their docking results
indicated that compound 1-4 (Fig. S2) interact with amino acid residue Tyr 121, Trp 279 (compound 1-5 (Fig. S2) interact with amino
acid residue Tyr 121) of AChE via hydrogen bond. In order to verify the effect of hydrogen of CH2CH2 of flexible chain, we selected
A5 and A8 to make a docking. The comparison of the docking A5, A6 and A8 (Fig. S4) suggests that, as the hydrogen on the flexible
chain was replaced by methyl and ethyl, the number of hydrogen bonds on the flexible chain dispeared, this also explained the
experimental result that when the hydrogen of CH2CH2 of flexible chain was replaced by methyl and ethyl groups, the nematicidal
activity decreased. We also made the molecular docking of A10 and A11 with the AChE (Fig. S5 in Supporting information), both
compound A10 and A11 interacts with amino acid residue Tyr121, Trp279, Tyr70, Trp84 and Phe330 of AChE via hydrogen bond and
π-π stacking. It is the same as that of compound A6. The docking results also indicated that all the active compounds had similiar
binding mode.
In conclusion, a novel series of chromone derivatives containing substituted pyrazole were designed and synthesized. The
nematocidal activity results showed some of them possessed good activity against M. incognita at 10.0 mg/L. The docking results
indicated that both compound A10 and A11 interacts with amino acid residue Tyr121, Trp279, Tyr70, Trp84 and Phe330 of AChE via
hydrogen bond and π-π stacking. It implied that chromone containing substituted pyrazole was a potential active structure to be worth
studying further.
Acknowledgments
This work was financial supported by the National Natural Science Foundation of China (No. 21672061), National Key Research
Program of China (No. 2017YFD0200505), and Fundamental Research Funds for the Central Universities (No. 222201718004).
References
[1] S.P. Castagnone, E.G. Danchin, B.L. Perfus, P. Abad, Annu. Rev. Phytopathol. 51 (2013) 203–220.
[2] J.N. Sasser, J.D. Eisenback, C.C. Carter, A.C. Triantaphyllou, Annu. Rev. Phytopathol. 21 (1983) 271−288.
[3] P.P. Reddy, Avermectins, in: P.P. Reddy, Recent advances in crop protection, Springer India, New Delhi, 2013, pp 13-24.
[4] I. Putter, J.G. MacConnell, F.A. Preiser, et al., Experientia 37 (1981) 963-964.
[5] D. Ross, T. Speir, Soil Biol. Biochem. 17 (1985) 123-125.
[6] C. Opperman, S. Chang, J. Nematol. 22 (1990) 481-481.
[7] C.G. Chavdarian, V.F. Heusinkveld, US 4737490, 1988.
[8] Y. Oka, M. Berson, A. Barazani, 5th International Congress of Nematology (2008) 313-314.
[9] Y. Oka, S. Shuker, N. Tkachi, Pest. Manag. Sci. 65 (2009) 1082-1089.
[10] D. Williams, M.W. Dimmic, W.J. Haakenson, Patent, WO 2009023721, 2009.
[11] M. Sajid, M.K. Azim, J. Agric. Food Chem. 60 (2012)7 428−7434.
[12] M. Isaka, M. Sappan, P. Auncharoen, P. Srikitikulchai, Phytochem. Lett. 3 (2010) 152-155.
[13] O. Prakash, R. Kumar, V. Parkash, Eur. J. Med. Chem. 43 (2008) 435-440.
[14] Y.U. Lee, I. Kawasaki, Y. Lim, et al., Mol. Cells 26 (2008) 171-174.
[15] Z.B. Wu, X. Zhou. Y.Q. Ye. P.Y. Wang. S. Yang. Chin. Chem. Lett. 28 (2017) 121–125.
[16] X.L. Deng, L. Zhang, X.P. Hu, et al., Chin. Chem. Lett. 27 (2016) 251–255.
[17] B.L. Wang, H.W. Zhu. Y. Ma, et al., J. Agric. Food Chem. 61(2013) 5483-5493.
[18] X.L. Deng. J. Xie. Y.Q. Li, et al., Chin. Chem. Lett. 27 (2016) 566–570.
[19] S. Wang. Y.J. Shi, H.B, et al., Chin. Chem. Lett. 26 (2015) 672–674.
[20] T. Schmidt, M. Puhl, J. Dickhaut, et al., Patent, EPO. WO 2007006670, 2007.
[21] J.L. Li, Z.C. Zhang, X.Y. Xu, X.S. Shao, Z. Li, Aust. J. Chem. 68 (2015) 1543-1549.
[22] X.L. Chen, Y.X. Xiao, G.L. Wang, Z. Li, X.Y. Xu, Res. Chem. Intermed. 42 (2016) 5495-5508.
[23] X.H. Liu, W. Zhao, Z.H. Shen, et al., Bioorg. Med. Chem. Lett. 26 (2016) 3626-3628.